http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017350895-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c89d7b810eae29b03c54afeac76166
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2015-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea7f3a80893f587315c46d2772e7d68b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_851664582fdab1f94ccdc10851f77355
publicationDate 2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017350895-A1
titleOfInvention Dcis recurrence and invasive breast cancer
abstract The present technology generally relates to methods and compositions relevant to the prediction that a subject with and/or after treatment for DCIS will experience a subsequent ipsilateral breast event that is a DCIS recurrence, an invasive breast cancer, both a DCIS recurrence and invasive cancer, or neither. The technology can assist one with how to treat such subjects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11288795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10489904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022226038-A1
priorityDate 2014-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226659166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226659165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135581853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23624148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21903888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539

Total number of triples: 56.